Biotechnology Center of The Fourth Military Medical University, 17 Changle West Road, 710032, Xi'an, People's Republic of China.
Cytotechnology. 2008 Feb;56(2):97-104. doi: 10.1007/s10616-007-9117-9. Epub 2007 Dec 30.
Tumor growth and metastasis depend on vessel formation, and inhibition of angiogenesis of tumor by production of anti-angiogenic drugs should be a promising approach for cancer therapy. Tumstatin is an angiogenesis inhibitor. The anti-angiogenic activity of tumstatin is localized to the 54-132 amino acids. The gene fragment encoding amino acids 45-132 of tumstatin (tum-5) was subcloned into pcDNA3.1 (pcDNA-tum5). Tum-5 protein could be expressed and secreted in CHO cells after transfection. The conditioned medium (containing tum-5 protein) from the transfectant has an anti-angiogenic effect on HUVEC cells in vitro. The anti-tumor effect of pcDNA-tum5 on mice bearing S180 tumors was evaluated. The results showed that pcDNA-tum-5 has a significant inhibition activity in the growth of the tumors. This study suggests that the gene delivery of tum-5 may be an effective strategy for cancer therapy.
肿瘤的生长和转移依赖于血管的形成,通过产生抗血管生成药物抑制肿瘤的血管生成应该是癌症治疗的一种有前途的方法。肿瘤抑素是一种血管生成抑制剂。肿瘤抑素的抗血管生成活性定位于 54-132 个氨基酸。编码肿瘤抑素氨基酸 45-132 片段的基因(tum-5)被亚克隆到 pcDNA3.1(pcDNA-tum5)中。转染后 CHO 细胞可表达和分泌 tum-5 蛋白。转染细胞的条件培养基(含有 tum-5 蛋白)在体外对 HUVEC 细胞具有抗血管生成作用。评价了 pcDNA-tum5 对荷 S180 肿瘤小鼠的抗肿瘤作用。结果表明,pcDNA-tum-5 对肿瘤的生长具有显著的抑制活性。本研究提示,tum-5 的基因传递可能是癌症治疗的一种有效策略。